Can-Fite BioPharma American Depositary Shares
CANF
5 hedge funds and large institutions have $2.39M invested in Can-Fite BioPharma American Depositary Shares in 2014 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
4,590% more capital invested
Capital invested by funds: $51K → $2.39M (+$2.34M)
400% more funds holding
Funds holding: 1 → 5 (+4)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.66M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$667K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$274K |
| 4 |
Morgan Stanley
New York
|
+$51.3K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$17.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.47M | +$1.66M | +97 | New |
|
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $587K | +$667K | +39 | New |
|
|
3
Hudson Bay Capital Management
Stamford,
Connecticut
| $249K | +$274K | +16 | New |
|
|
4
Morgan Stanley
New York
| $80K | +$51.3K | +3 | +150% |
|
|
U
5
UBS
Zurich,
Switzerland
| $8K | +$17.1K | +1 | New |
|
6
Citigroup
New York
| $2K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$7K | – | – |
|
CANF Hedge Fund Activity: Q1 2014 in Review
5 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q1 2014, worth a combined $2.39M — up 4,590% from $51K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CANF positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.66M. The largest seller was Tower Research Capital (TRC), cutting an estimated $7K.
- 5 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q1 2014, up from 1 in Q4 2013.
- Funds reported $2.39M of Can-Fite BioPharma American Depositary Shares stock for Q1 2014, up 4,590% quarter-over-quarter.
- 4 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q1 2014 and 0 closed out, a net change of +4 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q1 2014 was Susquehanna International Group, an estimated $1.66M added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q1 2014 was Tower Research Capital (TRC), an estimated $7K sold.
Based on aggregated 13F filings for Q1 2014.